Revance Therapeutics (NASDAQ:RVNC) PT Lowered to $41 00 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Revance Therapeutics (NASDAQ:RVNC – Get Free Report) released its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.80) earnings per share for the quarter, missing the consensus estimate of ($0.72) by ($0.08), Briefing.com reports. Revance Therapeutics had a negative net margin of 224.65% and a negative return on equity of 1,091.00%. The company had […]
Brokerages Set Revance Therapeutics, Inc (NASDAQ:RVNC) Price Target at $42 55 kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Waypoint Capital Advisors LLC raised its stake in shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Rating) by 68.5% during the 1st quarter, HoldingsChannel.com reports. The firm owned 90,989 shares of the biopharmaceutical company’s stock after acquiring an additional 37,000 shares during the quarter. Waypoint Capital Advisors LLC’s holdings in Revance Therapeutics were worth $2,930,000 […]